AI in Medical Insights: From Implementation to Impact in Medical Affairs
This article based on the Oct 3, 2024 Insights FAWG Forum explores the potential for artificial intelligence (AI) to transform Medical Affairs, focusing on medical insights.
Keeping it Real: Patient Engagement in Evidence Generation
In this webinar, we will discuss the regulatory bodies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly recognising the value of supplementing clinical trial data with real-world evidence to improve understanding of drug performance in the healthcare setting.
Regional Considerations and Challenges in Integrated Evidence Generation Planning (IEGP)
In this podcast, experts explore the many challenges associated with the operationalization of global Integrated Evidence Generation Planning (IEGP) at local levels.
Top 10 Most “Interesting” Publications of 2024
What makes a publication interesting or impactful? Is it number of citations? Sentiment among important stakeholders? Relevance to the largest patient population? Popular news attention? The answer depends on your strategy. Here we speak with experts from Altmetric about 10 publications that are impactful for different reasons.
The Changing Landscape of Journal Performance Measurement
Take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption.
Measuring the Impact of Medical Affairs: A data-driven modular approach
In this webinar, we will share new data showing that while medical affairs is increasing in importance, it is still struggling to reach a consensus around medical impact metrics. However, measuring medical impact is no longer a choice; it’s a necessity for medical to communicate its value as a business function and better demonstrate its contributions to successful patient outcomes.
2024 Benchmark Report: Digital, Advanced Analytics & Artificial Intelligence in Medical Affairs
MAPS’ 2024 Benchmark Report is based on findings from 32 organizations in Pharma and MedTech and reflects broad leadership thinking about the current and future states of AI capabilities and challenges in Medical Affairs.
Integrated Evidence Generation Planning (IEGP): Cross-functional alignment to optimize value, minimize risk
Experts from Lumanity discuss cross-functional alignment of Integrated Evidence Generation Planning (IEGP) from perspectives of strategy, clinical/regulatory, commercial and patient engagement.
Leveraging diverse data sources for more impactful insights analysis
The objective is to illustrate how determining the most effective medical or commercial strategy requires measuring what’s happening in the market via a strong insights management process.